|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Morice P, Leary A, Creutzberg C, AbuRustum
N and Darai E: Endometrial cancer. Lancet. 387:1094–1108. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Singh R: Review literature on uterine
carcinosarcoma. J Cancer Res Ther. 10:461–468. 2014.PubMed/NCBI
|
|
4
|
Zhang C, Hu W, Jia N, Li Q, Hua K, Tao X,
Wang L and Feng W: Uterine carcinosarcoma and high-risk endometrial
carcinomas: A clinicopathological comparison. Int J Gynecol Cancer.
25:629–636. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhu J, Wen H, Bi R and Wu X:
Clinicopathological characteristics, treatment and outcomes in
uterine carcinosarcoma and grade 3 endometrial cancer patients: A
comparative study. J Gynecol Oncol. 27:e182016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cantrell LA, Havrilesky L, Moore DT,
O'Malley D, Liotta M, Secord AA, Nagel CI, Cohn DE, Fader AN,
Wallace AH, et al: A multi-institutional cohort study of adjuvant
therapy in stage I–II uterine carcinosarcoma. Gynecol Oncol.
127:22–26. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nakamura K, Hongo A, Kodama J and
Hiramatsu Y: The pretreatment of maximum standardized uptake values
(SUVmax) of the primary tumor is predictor for poor
prognosis for patients with epithelial ovarian cancer. Acta Med
Okayama. 66:53–60. 2012.PubMed/NCBI
|
|
8
|
Tanizaki Y, Kobayashi A, Shiro M, Ota N,
Takano R, Mabuchi Y, Yagi S, Minami S, Terada M and Ino K:
Diagnostic value of preoperative SUVmax on FDG-PET/CT
for the detection of ovarian cancer. Int J Gynecol Cancer.
24:454–460. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kidd EA, Siegel BA, Dehdashti F and
Grigsby PW: The standardized uptake value for F-18
fluorodeoxyglucose is a sensitive predictive biomarker for cervical
cancer treatment response and survival. Cancer. 110:1738–1744.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee YY, Choi CH, Kim CJ, Kang H, Kim TJ,
Lee JW, Lee JH, Bae DS and Kim BG: The prognostic significance of
the SUVmax (maximum standardized uptake value for F-18
fluorodeoxyglucose) of the cervical tumor in PET imaging for early
cervical cancer: Preliminary results. Gynecol Oncol. 115:65–68.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nakamura K, Kodama J, Okumura Y, Hongo A,
Kanazawa S and Hiramatsu Y: The SUVmax of 18F-FDG PET
correlates with histological grade in endometrial cancer. Int J
Gynecol Cancer. 20:110–115. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Antonsen SL, Loft A, Fisker R, Nielsen AL,
Andersen ES, Høgdall E, Tabor A, Jochumsen K, Fagö-Olsen CL,
Asmussen J, et al: SUVmax of 18FDG PET/CT as a predictor
of high-risk endometrial cancer patients. Gynecol Oncol.
129:298–303. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nakamura K, Hongo A, Kodama J and
Hiramatsu Y: The measurement of SUVmax of the primary
tumor is predictive of prognosis for patients with endometrial
cancer. Gynecol Oncol. 123:82–87. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
WalentowiczSadlecka M, Malkowski B,
Walentowicz P, Sadlecki P, Marszalek A, Pietrzak T and Grabiec M:
The preoperative maximum standardized uptake value measured by
18F-FDG PET/CT as an independent prognostic factor of overall
survival in endometrial cancer patients. Biomed Res Int.
2014:2348132014.PubMed/NCBI
|
|
15
|
Kitajima K, Kita M, Suzuki K, Senda M,
Nakamoto Y and Sugimura K: Prognostic significance of
SUVmax (maximum standardized uptake value) measured by
[18F]FDG PET/CT in endometrial cancer. Eur J Nucl Med Mol Imaging.
39:840–845. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ghooshkhanei H, Treglia G, Sabouri G,
Davoodi R and Sadeghi R: Risk stratification and prognosis
determination using (18)F-FDG PET imaging in endometrial cancer
patients: A systematic review and meta-analysis. Gynecol Oncol.
132:669–676. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kitajima K, Suenaga Y, Ueno Y, Maeda T,
Ebina Y, Yamada H, Okunaga T, Kubo K, Sofue K, Kanda T, et al:
Preoperative risk stratification using metabolic parameters of
(18)F-FDG PET/CT in patients with endometrial cancer. Eur J Nucl
Med Mol Imaging. 42:1268–1275. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chung HH, Lee I, Kim HS, Kim JW, Park NH,
Song YS and Cheon GJ: Prognostic value of preoperative metabolic
tumor volume measured by 18F-FDG PET/CT and MRI in patients with
endometrial cancer. Gynecol Oncol. 130:446–451. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Husby JA, Reitan BC, Biermann M, Trovik J,
Bjørge L, Magnussen IJ, Salvesen ØO, Salvesen HB and Haldorsen IS:
Metabolic tumor volume on 18F-FDG PET/CT improves preoperative
identification of high-risk endometrial carcinoma patients. J Nucl
Med. 56:1191–1198. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee JW, Heo EJ, Moon SH, Lee H, Cheon GJ,
Lee M, Kim HS and Chung HH: Prognostic value of total lesion
glycolysis on preoperative 18F-FDG PET/CT in patients with uterine
carcinosarcoma. Eur Radiol. Feb 16–2016.(Epub ahead of print).
View Article : Google Scholar
|
|
21
|
Kidd EA and Grigsby PW: Intratumoral
metabolic heterogeneity of cervical cancer. Clin Cancer Res.
14:5236–5241. 2008. View Article : Google Scholar : PubMed/NCBI
|
